QLYS Form 4: Bruce Posey Reports 525-Share Sale via 10b5-1 Plan
Rhea-AI Filing Summary
Bruce K. Posey, Chief Legal Officer of Qualys, Inc. (QLYS), reported sales of common stock on 08/20/2025 executed under a Rule 10b5-1 trading plan adopted on 08/21/2024. The Form 4 discloses three sale entries: 308 shares at a weighted average price of $131.8922, 192 shares at $132.7383, and 25 shares at $133.618, leaving the reporting person with 57,840 shares beneficially owned after the transactions.
The filing indicates the sales were planned pursuant to the pre-established 10b5-1 plan and provides price ranges for the component trades. The reporting person signed the Form 4 on 08/21/2025. All information above is taken directly from the filed Form 4.
Positive
- Transactions were executed under a Rule 10b5-1 plan, indicating pre-planned, procedural sales
- Filing provides weighted average prices and price ranges for transparency
- Form 4 is signed and filed, meeting disclosure requirements
Negative
- Officer sold 525 shares, reducing beneficial ownership to 57,840 shares
- No information on total percentage ownership of the company is provided in this filing
Insights
TL;DR: Insider sales were executed under a pre-established 10b5-1 plan; transaction sizes are modest relative to typical insider holdings.
The filing shows scheduled dispositions by the Chief Legal Officer executed under a Rule 10b5-1 plan adopted in August 2024. The reported sales total 525 shares across three trades at weighted average prices between $131.89 and $133.62, resulting in 57,840 shares remaining beneficially owned. From a regulatory and governance perspective, use of a 10b5-1 plan signals the transactions were pre-planned to avoid timing concerns. The filing contains explicit per-trade weighted average prices and ranges and is procedurally complete.
TL;DR: Disclosure is compliant and transparent about the 10b5-1 plan and weighted-average pricing ranges.
The Form 4 clearly states the trades were effected pursuant to a Rule 10b5-1 trading plan and provides weighted average prices and price ranges for each reported sale. The reporting person attested and signed the Form 4 on 08/21/2025. There are no derivative transactions reported and the filing identifies the reporting person as an officer (Chief Legal Officer). This is a routine, non-material disclosure in the absence of other context in the filing.